Treatment of relapsing multiple sclerosis in Hungary – consensus recommendation from the Hungarian neuroimmunology society

Abstract Multiple sclerosis (MS) may impact quality of life, careers and family plans of the affected individuals. The current treatments with disease modifying therapies aim to prevent people with MS (pwMS) from disability accumulation and progression. Different countries have different reimburseme...

Full description

Bibliographic Details
Main Authors: Cecilia Rajda, Csilla Rózsa, Andrea Mike, Gábor Lovas, Zsolt Mezei, Gábor Jakab, Péter Ács, Gábor Rum, Magdolna Simó, Zita Jobbágy, Zita Bíró, Anita Trauninger, Piroska Imre, Klotild Mátyás, István Deme, Zsolt Illés, Tunde Csepany
Format: Article
Language:English
Published: BMC 2023-07-01
Series:Orphanet Journal of Rare Diseases
Subjects:
Online Access:https://doi.org/10.1186/s13023-023-02789-0
_version_ 1797784447870828544
author Cecilia Rajda
Csilla Rózsa
Andrea Mike
Gábor Lovas
Zsolt Mezei
Gábor Jakab
Péter Ács
Gábor Rum
Magdolna Simó
Zita Jobbágy
Zita Bíró
Anita Trauninger
Piroska Imre
Klotild Mátyás
István Deme
Zsolt Illés
Tunde Csepany
author_facet Cecilia Rajda
Csilla Rózsa
Andrea Mike
Gábor Lovas
Zsolt Mezei
Gábor Jakab
Péter Ács
Gábor Rum
Magdolna Simó
Zita Jobbágy
Zita Bíró
Anita Trauninger
Piroska Imre
Klotild Mátyás
István Deme
Zsolt Illés
Tunde Csepany
author_sort Cecilia Rajda
collection DOAJ
description Abstract Multiple sclerosis (MS) may impact quality of life, careers and family plans of the affected individuals. The current treatments with disease modifying therapies aim to prevent people with MS (pwMS) from disability accumulation and progression. Different countries have different reimbursement policies resulting in inequalities in patient care among geographical regions. Access to anti-CD20 therapies for relapsing MS is restricted in Hungary because therapy of individual cases only is reimbursed. In the light of the latest research and national guidelines, 17 Hungarian MS experts agreed on 8 recommendations regarding relapsing pwMS using the Delphi round method. Strong agreement (> 80%) was achieved in all except one recommendation after three rounds, which generated a fourth Delphi round. The experts agreed on treatment initiation, switch, follow-up and discontinuation, as well as on special issues such as pregnancy, lactation, elderly population, and vaccination. Well-defined national consensus protocols may facilitate dialogue between policymakers and healthcare professionals and thus contribute to better patient care in the long run.
first_indexed 2024-03-13T00:40:00Z
format Article
id doaj.art-be59c2447b67412d8c543f4314d3ae5c
institution Directory Open Access Journal
issn 1750-1172
language English
last_indexed 2024-03-13T00:40:00Z
publishDate 2023-07-01
publisher BMC
record_format Article
series Orphanet Journal of Rare Diseases
spelling doaj.art-be59c2447b67412d8c543f4314d3ae5c2023-07-09T11:24:55ZengBMCOrphanet Journal of Rare Diseases1750-11722023-07-011811810.1186/s13023-023-02789-0Treatment of relapsing multiple sclerosis in Hungary – consensus recommendation from the Hungarian neuroimmunology societyCecilia Rajda0Csilla Rózsa1Andrea Mike2Gábor Lovas3Zsolt Mezei4Gábor Jakab5Péter Ács6Gábor Rum7Magdolna Simó8Zita Jobbágy9Zita Bíró10Anita Trauninger11Piroska Imre12Klotild Mátyás13István Deme14Zsolt Illés15Tunde Csepany16Department of Neurology, Albert Szent-Györgyi Health Centre, University of SzegedDepartment of Neurology, Jahn Ferenc Teaching HospitalDepartment of Neurology, Szent Borbála HospitalDepartment of Neurology, Jahn Ferenc Teaching HospitalDepartment of Neurology, Faculty of Medicine, Semmelweis UniversityDepartment of Neurology, Uzsoki HospitalDepartment of Neurology, Medical School, University of PécsPetz Aladár Department of Neurology, County Teaching HospitalDepartment of Neurology, Faculty of Medicine, Semmelweis UniversityDepartment of Neurology, Bács-Kiskun County Teaching HospitalDepartment of Neurology, Flór Ferenc HospitalDepartment of Neurology, Medical School, University of PécsDepartment of Neurology, Csolnoky Ferenc HospitalDepartment of Neurology, Markhot Ferenc Teaching HospitalDepartment of Neurology, Kaposi Mór Teaching HospitalDepartment of Neurology, Odense University Hospital, Institute of Clinical Research, University of Southern DenmarkDepartment of Neurology, Faculty of Medicine, University of DebrecenAbstract Multiple sclerosis (MS) may impact quality of life, careers and family plans of the affected individuals. The current treatments with disease modifying therapies aim to prevent people with MS (pwMS) from disability accumulation and progression. Different countries have different reimbursement policies resulting in inequalities in patient care among geographical regions. Access to anti-CD20 therapies for relapsing MS is restricted in Hungary because therapy of individual cases only is reimbursed. In the light of the latest research and national guidelines, 17 Hungarian MS experts agreed on 8 recommendations regarding relapsing pwMS using the Delphi round method. Strong agreement (> 80%) was achieved in all except one recommendation after three rounds, which generated a fourth Delphi round. The experts agreed on treatment initiation, switch, follow-up and discontinuation, as well as on special issues such as pregnancy, lactation, elderly population, and vaccination. Well-defined national consensus protocols may facilitate dialogue between policymakers and healthcare professionals and thus contribute to better patient care in the long run.https://doi.org/10.1186/s13023-023-02789-0ConsensusMultiple sclerosisRecommendationTreatment
spellingShingle Cecilia Rajda
Csilla Rózsa
Andrea Mike
Gábor Lovas
Zsolt Mezei
Gábor Jakab
Péter Ács
Gábor Rum
Magdolna Simó
Zita Jobbágy
Zita Bíró
Anita Trauninger
Piroska Imre
Klotild Mátyás
István Deme
Zsolt Illés
Tunde Csepany
Treatment of relapsing multiple sclerosis in Hungary – consensus recommendation from the Hungarian neuroimmunology society
Orphanet Journal of Rare Diseases
Consensus
Multiple sclerosis
Recommendation
Treatment
title Treatment of relapsing multiple sclerosis in Hungary – consensus recommendation from the Hungarian neuroimmunology society
title_full Treatment of relapsing multiple sclerosis in Hungary – consensus recommendation from the Hungarian neuroimmunology society
title_fullStr Treatment of relapsing multiple sclerosis in Hungary – consensus recommendation from the Hungarian neuroimmunology society
title_full_unstemmed Treatment of relapsing multiple sclerosis in Hungary – consensus recommendation from the Hungarian neuroimmunology society
title_short Treatment of relapsing multiple sclerosis in Hungary – consensus recommendation from the Hungarian neuroimmunology society
title_sort treatment of relapsing multiple sclerosis in hungary consensus recommendation from the hungarian neuroimmunology society
topic Consensus
Multiple sclerosis
Recommendation
Treatment
url https://doi.org/10.1186/s13023-023-02789-0
work_keys_str_mv AT ceciliarajda treatmentofrelapsingmultiplesclerosisinhungaryconsensusrecommendationfromthehungarianneuroimmunologysociety
AT csillarozsa treatmentofrelapsingmultiplesclerosisinhungaryconsensusrecommendationfromthehungarianneuroimmunologysociety
AT andreamike treatmentofrelapsingmultiplesclerosisinhungaryconsensusrecommendationfromthehungarianneuroimmunologysociety
AT gaborlovas treatmentofrelapsingmultiplesclerosisinhungaryconsensusrecommendationfromthehungarianneuroimmunologysociety
AT zsoltmezei treatmentofrelapsingmultiplesclerosisinhungaryconsensusrecommendationfromthehungarianneuroimmunologysociety
AT gaborjakab treatmentofrelapsingmultiplesclerosisinhungaryconsensusrecommendationfromthehungarianneuroimmunologysociety
AT peteracs treatmentofrelapsingmultiplesclerosisinhungaryconsensusrecommendationfromthehungarianneuroimmunologysociety
AT gaborrum treatmentofrelapsingmultiplesclerosisinhungaryconsensusrecommendationfromthehungarianneuroimmunologysociety
AT magdolnasimo treatmentofrelapsingmultiplesclerosisinhungaryconsensusrecommendationfromthehungarianneuroimmunologysociety
AT zitajobbagy treatmentofrelapsingmultiplesclerosisinhungaryconsensusrecommendationfromthehungarianneuroimmunologysociety
AT zitabiro treatmentofrelapsingmultiplesclerosisinhungaryconsensusrecommendationfromthehungarianneuroimmunologysociety
AT anitatrauninger treatmentofrelapsingmultiplesclerosisinhungaryconsensusrecommendationfromthehungarianneuroimmunologysociety
AT piroskaimre treatmentofrelapsingmultiplesclerosisinhungaryconsensusrecommendationfromthehungarianneuroimmunologysociety
AT klotildmatyas treatmentofrelapsingmultiplesclerosisinhungaryconsensusrecommendationfromthehungarianneuroimmunologysociety
AT istvandeme treatmentofrelapsingmultiplesclerosisinhungaryconsensusrecommendationfromthehungarianneuroimmunologysociety
AT zsoltilles treatmentofrelapsingmultiplesclerosisinhungaryconsensusrecommendationfromthehungarianneuroimmunologysociety
AT tundecsepany treatmentofrelapsingmultiplesclerosisinhungaryconsensusrecommendationfromthehungarianneuroimmunologysociety